BIOCRYST PHARMACEUTICALS, INC. Operating Income
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Operating Income of $98.47 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-05
- BIOCRYST PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2026-06-30 was $98.47M, a 230.57% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2026-03-31 was -$701.60M, a 3405.22% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2025-12-31 was $260.38M.
- BIOCRYST PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2025-09-30 was $29.59M, a 284.70% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. operating income (loss) for fiscal 2025 was $340.99M.
- BIOCRYST PHARMACEUTICALS, INC. operating income (loss) for fiscal 2024 was -$2.54M.
- BIOCRYST PHARMACEUTICALS, INC. operating income (loss) for fiscal 2023 was -$103.71M.
- BIOCRYST PHARMACEUTICALS, INC. operating income (loss) for fiscal 2022 was -$148.44M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $98.47M 10-Q · filed 2026-08-05 | -$603.13M 10-Q · filed 2026-08-05 | -$342.75M derived: sum of 3 quarters · filed 2026-08-05 | -$313.16M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$701.60M 10-Q · filed 2026-05-06 | -$441.21M derived: sum of 2 quarters · filed 2026-05-06 | -$411.62M derived: sum of 3 quarters · filed 2026-05-06 | -$381.84M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $260.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $289.98M derived: sum of 2 quarters · filed 2026-02-26 | $319.76M derived: sum of 3 quarters · filed 2026-08-05 | $340.99M 10-K · filed 2026-02-26 |
| 2025-09-30 | $29.59M 10-Q · filed 2025-11-04 | $59.38M derived: sum of 2 quarters · filed 2026-08-05 | $80.60M 10-Q · filed 2025-11-04 | $76.10M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $29.79M 10-Q · filed 2026-08-05 | $51.01M 10-Q · filed 2026-08-05 | $46.51M derived: sum of 3 quarters · filed 2026-08-05 | $54.20M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $21.23M 10-Q · filed 2026-05-06 | $16.72M derived: sum of 2 quarters · filed 2026-05-06 | $24.41M derived: sum of 3 quarters · filed 2026-05-06 | $33.17M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$4.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.18M derived: sum of 2 quarters · filed 2026-02-26 | $11.95M derived: sum of 3 quarters · filed 2026-02-26 | -$2.54M 10-K · filed 2026-02-26 |
| 2024-09-30 | $7.69M 10-Q · filed 2025-11-04 | $16.45M derived: sum of 2 quarters · filed 2025-11-04 | $1.97M 10-Q · filed 2025-11-04 | -$40.70M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $8.76M 10-Q · filed 2025-08-05 | -$5.73M 10-Q · filed 2025-08-05 | -$48.40M derived: sum of 3 quarters · filed 2026-02-26 | -$60.32M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$14.49M 10-Q · filed 2025-05-06 | -$57.16M derived: sum of 2 quarters · filed 2026-02-26 | -$69.08M derived: sum of 3 quarters · filed 2026-02-26 | -$89.78M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$42.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$54.59M derived: sum of 2 quarters · filed 2026-02-26 | -$75.29M derived: sum of 3 quarters · filed 2026-02-26 | -$103.71M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$11.92M 10-Q · filed 2024-11-05 | -$32.62M derived: sum of 2 quarters · filed 2024-11-05 | -$61.04M 10-Q · filed 2024-11-05 | -$107.35M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | -$20.70M 10-Q · filed 2024-08-06 | -$49.12M 10-Q · filed 2024-08-06 | -$95.43M derived: sum of 3 quarters · filed 2025-02-25 | -$112.87M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | -$28.41M 10-Q · filed 2024-05-07 | -$74.73M derived: sum of 2 quarters · filed 2025-02-25 | -$92.17M derived: sum of 3 quarters · filed 2025-02-25 | -$126.89M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | -$46.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$63.76M derived: sum of 2 quarters · filed 2025-02-25 | -$98.48M derived: sum of 3 quarters · filed 2025-02-25 | -$148.44M 10-K · filed 2025-02-25 |
| 2022-09-30 | -$17.45M 10-Q · filed 2023-11-08 | -$52.17M derived: sum of 2 quarters · filed 2023-11-08 | -$102.12M 10-Q · filed 2023-11-08 | -$154.30M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$34.72M 10-Q · filed 2023-08-07 | -$84.68M 10-Q · filed 2023-08-07 | -$136.86M derived: sum of 3 quarters · filed 2024-02-27 | -$181.44M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$49.96M 10-Q · filed 2023-05-08 | -$102.13M derived: sum of 2 quarters · filed 2024-02-27 | -$146.72M derived: sum of 3 quarters · filed 2024-02-27 | -$176.30M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$52.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$96.76M derived: sum of 2 quarters · filed 2024-02-27 | -$126.34M derived: sum of 3 quarters · filed 2024-02-27 | -$177.72M 10-K · filed 2024-02-27 |
| 2021-09-30 | -$44.58M 10-Q · filed 2022-11-04 | -$74.17M derived: sum of 2 quarters · filed 2022-11-04 | -$125.54M 10-Q · filed 2022-11-04 | -$177.95M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | -$29.58M 10-Q · filed 2022-08-05 | -$80.96M 10-Q · filed 2022-08-05 | -$133.36M derived: sum of 3 quarters · filed 2023-02-27 | -$176.23M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | -$51.38M 10-Q · filed 2022-05-09 | -$103.78M derived: sum of 2 quarters · filed 2023-02-27 | -$146.65M derived: sum of 3 quarters · filed 2023-02-27 | -$185.16M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | -$52.41M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$95.27M derived: sum of 2 quarters · filed 2023-02-27 | -$133.78M derived: sum of 3 quarters · filed 2023-02-27 | -$174.76M 10-K · filed 2023-02-27 |
| 2020-09-30 | -$42.86M 10-Q · filed 2021-11-04 | -$81.37M derived: sum of 2 quarters · filed 2021-11-04 | -$122.35M 10-Q · filed 2021-11-04 | -$122.46M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$38.51M 10-Q · filed 2021-08-09 | -$79.49M 10-Q · filed 2021-08-09 | -$79.60M derived: sum of 3 quarters · filed 2022-02-28 | -$114.69M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$40.98M 10-Q · filed 2021-05-07 | -$41.09M derived: sum of 2 quarters · filed 2022-02-28 | -$76.19M derived: sum of 3 quarters · filed 2022-02-28 | -$111.10M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$35.21M derived: sum of 2 quarters · filed 2022-02-28 | -$70.13M derived: sum of 3 quarters · filed 2022-02-28 | -$99.45M 10-K · filed 2022-02-28 |
| 2019-09-30 | -$35.10M 10-Q · filed 2020-11-06 | -$70.02M derived: sum of 2 quarters · filed 2020-11-06 | -$99.35M 10-Q · filed 2020-11-06 | -$124.61M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | -$34.92M 10-Q · filed 2020-08-07 | -$64.25M 10-Q · filed 2020-08-07 | -$89.51M derived: sum of 3 quarters · filed 2021-03-01 | -$118.00M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | -$29.33M 10-Q · filed 2020-05-11 | -$54.59M derived: sum of 2 quarters · filed 2021-03-01 | -$83.08M derived: sum of 3 quarters · filed 2021-03-01 | -$101.34M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$25.26M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$53.76M derived: sum of 2 quarters · filed 2021-03-01 | -$72.01M derived: sum of 3 quarters · filed 2021-03-01 | -$94.22M 10-K · filed 2021-03-01 |
| 2018-09-30 | -$28.49M 10-Q · filed 2019-11-08 | -$46.74M derived: sum of 2 quarters · filed 2019-11-08 | -$68.96M 10-Q · filed 2019-11-08 | -$86.82M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-06-30 | -$18.25M 10-Q · filed 2019-08-08 | -$40.47M 10-Q · filed 2019-08-08 | -$58.33M derived: sum of 3 quarters · filed 2020-03-13 | -$71.67M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-03-31 | -$22.21M 10-Q · filed 2019-05-09 | -$40.08M derived: sum of 2 quarters · filed 2020-03-13 | -$53.42M derived: sum of 3 quarters · filed 2020-03-13 | -$68.94M derived: sum of 4 quarters · filed 2020-03-13 |
| 2017-12-31 | -$17.86M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$31.21M derived: sum of 2 quarters · filed 2020-03-13 | -$46.73M derived: sum of 3 quarters · filed 2020-03-13 | -$57.41M 10-K · filed 2020-03-13 |
| 2017-09-30 | -$13.35M 10-Q · filed 2018-11-08 | -$28.86M derived: sum of 2 quarters · filed 2018-11-08 | -$39.55M 10-Q · filed 2018-11-08 | -$47.74M derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-06-30 | -$15.52M 10-Q · filed 2018-08-09 | -$26.20M 10-Q · filed 2018-08-09 | -$34.39M derived: sum of 3 quarters · filed 2019-03-14 | -$43.63M derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-03-31 | -$10.69M 10-Q · filed 2018-05-09 | -$18.87M derived: sum of 2 quarters · filed 2019-03-14 | -$28.11M derived: sum of 3 quarters · filed 2019-03-14 | -$40.24M derived: sum of 4 quarters · filed 2019-03-14 |
| 2016-12-31 | -$8.19M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$17.43M derived: sum of 2 quarters · filed 2019-03-14 | -$29.56M derived: sum of 3 quarters · filed 2019-03-14 | -$48.61M 10-K · filed 2019-03-14 |
| 2016-09-30 | -$9.24M 10-Q · filed 2017-11-08 | -$21.37M derived: sum of 2 quarters · filed 2017-11-08 | -$40.42M 10-Q · filed 2017-11-08 | -$57.61M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | -$12.13M 10-Q · filed 2017-08-08 | -$31.18M 10-Q · filed 2017-08-08 | -$48.37M derived: sum of 3 quarters · filed 2018-03-12 | -$61.53M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | -$19.05M 10-Q · filed 2017-05-08 | -$36.24M derived: sum of 2 quarters · filed 2018-03-12 | -$49.40M derived: sum of 3 quarters · filed 2018-03-12 | -$44.06M derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | -$17.19M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$30.36M derived: sum of 2 quarters · filed 2018-03-12 | -$25.01M derived: sum of 3 quarters · filed 2018-03-12 | -$39.44M 10-K · filed 2018-03-12 |
| 2015-09-30 | -$13.16M 10-Q · filed 2016-11-08 | -$7.82M derived: sum of 2 quarters · filed 2016-11-08 | -$22.25M 10-Q · filed 2016-11-08 | -$37.41M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | $5.34M 10-Q · filed 2016-08-08 | -$9.09M 10-Q · filed 2016-08-08 | -$24.24M derived: sum of 3 quarters · filed 2017-02-27 | -$35.85M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | -$14.43M 10-Q · filed 2016-05-09 | -$29.59M derived: sum of 2 quarters · filed 2017-02-27 | -$41.20M derived: sum of 3 quarters · filed 2017-02-27 | -$52.81M derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | -$15.16M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | -$26.77M derived: sum of 2 quarters · filed 2017-02-27 | -$38.38M derived: sum of 3 quarters · filed 2017-02-27 | -$45.77M 10-K · filed 2017-02-27 |
| 2014-09-30 | -$11.61M 10-Q · filed 2015-11-06 | -$23.23M derived: sum of 2 quarters · filed 2015-11-06 | -$30.61M 10-Q · filed 2015-11-06 | -$36.95M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | -$11.62M 10-Q · filed 2015-08-07 | -$19.00M 10-Q · filed 2015-08-07 | -$25.34M derived: sum of 3 quarters · filed 2016-02-26 | -$32.26M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | -$7.39M 10-Q · filed 2015-05-08 | -$13.72M derived: sum of 2 quarters · filed 2016-02-26 | -$20.64M derived: sum of 3 quarters · filed 2016-02-26 | -$32.79M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | -$6.33M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | -$13.26M derived: sum of 2 quarters · filed 2016-02-26 | -$25.40M derived: sum of 3 quarters · filed 2016-02-26 | -$30.72M 10-K · filed 2016-02-26 |
| 2013-09-30 | -$6.92M 10-Q · filed 2014-11-07 | -$19.07M derived: sum of 2 quarters · filed 2014-11-07 | -$24.38M 10-Q · filed 2014-11-07 | -$35.08M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | -$12.14M 10-Q · filed 2014-08-08 | -$17.46M 10-Q · filed 2014-08-08 | -$28.15M derived: sum of 3 quarters · filed 2015-03-02 | -$36.17M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | -$5.32M 10-Q · filed 2014-05-09 | -$16.01M derived: sum of 2 quarters · filed 2015-03-02 | -$24.03M derived: sum of 3 quarters · filed 2015-03-02 | -$34.20M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | -$10.70M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$18.71M derived: sum of 2 quarters · filed 2015-03-02 | -$28.89M derived: sum of 3 quarters · filed 2015-03-02 | -$33.89M 10-K · filed 2015-03-02 |
| 2012-09-30 | -$8.02M 10-Q · filed 2013-11-08 | -$18.19M derived: sum of 2 quarters · filed 2013-11-08 | -$23.19M 10-Q · filed 2013-11-08 | -$34.23M derived: sum of 4 quarters · filed 2014-03-10 |
| 2012-06-30 | -$10.18M 10-Q · filed 2013-08-08 | -$15.18M 10-Q · filed 2013-08-08 | -$26.22M derived: sum of 3 quarters · filed 2014-03-10 | -$39.02M derived: sum of 4 quarters · filed 2014-03-10 |
| 2012-03-31 | -$5.00M 10-Q · filed 2013-05-09 | -$16.04M derived: sum of 2 quarters · filed 2014-03-10 | -$28.85M derived: sum of 3 quarters · filed 2014-03-10 | -$43.09M derived: sum of 4 quarters · filed 2014-03-10 |
| 2011-12-31 | -$11.04M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | -$23.85M derived: sum of 2 quarters · filed 2014-03-10 | -$38.09M derived: sum of 3 quarters · filed 2014-03-10 | -$49.59M 10-K · filed 2014-03-10 |
| 2011-09-30 | -$12.80M 10-Q · filed 2012-11-08 | -$27.05M derived: sum of 2 quarters · filed 2012-11-08 | -$38.55M 10-Q · filed 2012-11-08 | -$48.85M derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-06-30 | -$14.24M 10-Q · filed 2012-08-08 | -$25.74M 10-Q · filed 2012-08-08 | -$36.05M derived: sum of 3 quarters · filed 2013-03-11 | -$47.04M derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-03-31 | -$11.50M 10-Q · filed 2012-05-08 | -$21.81M derived: sum of 2 quarters · filed 2013-03-11 | -$32.80M derived: sum of 3 quarters · filed 2013-03-11 | -$43.13M derived: sum of 4 quarters · filed 2013-03-11 |
| 2010-12-31 | -$10.31M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | -$21.30M derived: sum of 2 quarters · filed 2013-03-11 | -$31.63M derived: sum of 3 quarters · filed 2013-03-11 | -$34.36M 10-K · filed 2013-03-11 |
| 2010-09-30 | -$10.99M 10-Q · filed 2011-11-03 | -$21.32M derived: sum of 2 quarters · filed 2011-11-03 | -$24.05M 10-Q · filed 2011-11-03 | |
| 2010-06-30 | -$10.33M 10-Q · filed 2011-08-04 | -$13.06M 10-Q · filed 2011-08-04 | ||
| 2009-12-31 | -$13.74M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |